Chongqing Pharscin Pharmaceutical Co Ltd (002907) — Cash Flow-to-Debt Ratio
Chongqing Pharscin Pharmaceutical Co Ltd (002907) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥833.94K could theoretically repay 0% of its total liabilities (CN¥287.66 Million) in one year. See 002907 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Chongqing Pharscin Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Chongqing Pharscin Pharmaceutical Co Ltd across 12 annual periods. Also explore Chongqing Pharscin Pharmaceutical Co Ltd (002907) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Chongqing Pharscin Pharmaceutical Co Ltd (2013–2024)
Year-by-year debt coverage analysis for Chongqing Pharscin Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see how much is Chongqing Pharscin Pharmaceutical Co Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.63x | CN¥161.77 Million | CN¥257.55 Million | ▼ -33.1% |
| 2023 | 0.94x | CN¥219.34 Million | CN¥233.53 Million | ▲ +1745.2% |
| 2022 | 0.05x | CN¥13.04 Million | CN¥256.28 Million | ▼ -68.9% |
| 2021 | 0.16x | CN¥82.85 Million | CN¥505.56 Million | ▼ -22.2% |
| 2020 | 0.21x | CN¥113.64 Million | CN¥539.59 Million | ▲ +81.0% |
| 2019 | 0.12x | CN¥65.92 Million | CN¥566.67 Million | ▼ -3.2% |
| 2018 | 0.12x | CN¥31.80 Million | CN¥264.72 Million | ▼ -75.6% |
| 2017 | 0.49x | CN¥81.34 Million | CN¥165.20 Million | ▲ +62.8% |
| 2016 | 0.30x | CN¥57.73 Million | CN¥190.91 Million | ▼ -20.6% |
| 2015 | 0.38x | CN¥66.10 Million | CN¥173.59 Million | ▲ +347.5% |
| 2014 | 0.09x | CN¥20.22 Million | CN¥237.62 Million | ▼ -68.7% |
| 2013 | 0.27x | CN¥47.34 Million | CN¥174.39 Million | — |